Product Information
VASCEPA 0.5 GM CAPSULE is a brand product labeled by Amarin Pharma Inc., priced at $1.6611 per EA under NDC 52937000340. Its NADAC has been published 359 times since Nov 22, 2017.
The High Outlier badge above means this manufacturer's average price in the icosapent ethyl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Amarin Pharma Inc.NDC
52937000340
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
9/18/2024
Active Ingredients
ICOSAPENT ETHYLApproval Type
New Drug (NDA)
FDA Application
NDA202057On Market Since
9/16/2016
Price Statistics
The NADAC for VASCEPA 0.5 GM CAPSULE has been published 359 times since Nov 22, 2017, and over the history we have for it it has risen 38.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6611 per EA |
|---|---|
| All-time high | $1.6723 (Apr 10, 2024) |
| All-time low | $1.1976 (Nov 22, 2017) |
| Median price | $1.6117 |
| Average price | $1.5459 |
| Largest weekly change | +9.0% (Jan 3, 2018) |
| Weeks tracked | 359 |
| Tracking since | Nov 22, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the icosapent ethyl market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VASCEPA 0.5 GM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VASCEPA 0.5 GM CAPSULE, manufactured by Amarin Pharma Inc., is $1.6611 per EA (NDC 52937000340), effective Oct 2, 2024.
How has the price of VASCEPA 0.5 GM CAPSULE changed over time?
Over the history we have for it, the NADAC for VASCEPA 0.5 GM CAPSULE has risen 38.7%. It has been tracked across 359 weekly CMS publications since Nov 22, 2017.
What are the highest and lowest recorded NADAC prices for VASCEPA 0.5 GM CAPSULE?
Since Nov 22, 2017, the NADAC for VASCEPA 0.5 GM CAPSULE has ranged from a low of $1.1976 (Nov 22, 2017) to a high of $1.6723 (Apr 10, 2024), with a median of $1.6117 per EA.
Are there cheaper alternatives to VASCEPA 0.5 GM CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VASCEPA 0.5 GM CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures VASCEPA 0.5 GM CAPSULE?
VASCEPA 0.5 GM CAPSULE (NDC 52937000340) is labeled by Amarin Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification